Neurotech: Virtual clinical trials: What investigators are learning about the challenge and opportunities

An excerpt from Neurology Today; Read the full article.

Virtual technology, which bridges the gap between doctors and specialists or patients by enabling real-time consultation, is making its way to large multicenter clinical trials. The ability to gather data through open websites, smartphones, or tablets is enabling investigators to pull data from more geographically, ethnically, and socioeconomically diverse sources, experts in the field told Neurology Today, and patients are spared the inconvenience and potential safety risks of traveling great distances to academic centers where trials are conducted.

“I think a fundamental flaw in the way we conduct clinical trials is that we ask people to participate in these trials on our terms,” said Ray Dorsey, MD, MBA, the David M. Levy Professor of Neurology and director of the Center for Health and Technology at the University of Rochester Medical Center, who is spearheading research on the benefits of virtual visits in neurologic disease trials.

“Virtual trials enable people to participate on their terms. The trial comes to them. Instead of a site-centric approach, all activities are centered on the participants,” Dr. Dorsey said. “We can conduct studies that span borders and long time periods. This is especially important for rare neurological disorders. It enables people to participate in studies from parts of world where there may not be a specialist in their condition.”

Excerpted from Neurology Today.

Read the full article.

Posted: Sept. 7, 2017